Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
The Journal of Experimental Medicine|October 26, 2011
Assembling defenses against therapy-resistant leukemic stem cells: Bcl6 joins the ranksFrancesca Pellicano, Tessa L HolyoakeStem Cells (Dayton, Ohio)|February 13, 2014
Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure for more effective targetingFrancesca Pellicano, Leena Mukherjee, Tessa L HolyoakeCurrent Hematologic Malignancy Reports|March 5, 2011
In search of CML stem cells' deadly weaknessFrancesca Pellicano, Amy Sinclair, Tessa L HolyoakeBlood|September 10, 2009
BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38- cells, through activation of protein kinase CbetaFrancesca Pellicano, Mhairi Copland, Heather G Jorgensen, et al.Blood|December 25, 2007
BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitorsMhairi Copland, Francesca Pellicano, Linda Richmond, et al.Blood|September 18, 2013
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferationPaolo Gallipoli, Francesca Pellicano, Heather Morrison, et al.Proteomics|November 28, 2012
Quantitative proteomics analysis of BMS-214662 effects on CD34 positive cells from chronic myeloid leukaemia patientsStefan Balabanov, Caroline A Evans, Sheela A Abraham, et al.Blood|February 5, 2017
The chronic myeloid leukemia stem cell: stemming the tide of persistenceTessa L Holyoake, David VetrieNature Protocols|December 19, 2014
Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell linesMark Aspinall-O'Dea, Andrew Pierce, Francesca Pellicano, et al.Hematological Oncology|April 19, 2007
Therapeutic targets in chronic myeloid leukaemiaNicholas B Heaney, Tessa L HolyoakePageof 11